Clinical Trials Directory

Trials / Unknown

UnknownNCT00555776

Effect of Gabapentin on Idiopathic Subjective Tinnitus

Phase 2 Effect of Gabapentin on Idiopathic Subjective Tinnitus

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Islamic Azad University of Mashhad · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine wether Gabapentin which is useful for treating neuropathic pains, is effective on idiopathic subjective tinnitus.

Detailed description

Tinnitus is the perception of sound in the absence of acoustic stimulation. It can be subjective or objective. . Despite numerous researches,no effective treatment for people who suffer from tinnitus has yet been stablished. As there are many evidences suggesting that loss of inhibition in the central nervous system may be responsible for many aspects of auditory dysfunction,including tinnitus; and as Gabapentin (Neurontin), a gama-aminobutyric acid (GABA) analogue, is an effective medication in conditions where inhibition in the CNS is impaired; we guess that Gabapentin might be useful for treating idiopathic subjective tinnitus.

Conditions

Interventions

TypeNameDescription
DRUGGabapentinGabapentin, 600 mg bid for the first two weeks, increased to a maximum dose of 1800 mg per day during the next 6 weeks if necessary.
DRUGplaceboplacebo is given with the same definition as Gabapentin

Timeline

Start date
2007-01-01
Primary completion
2008-04-01
Completion
2008-10-01
First posted
2007-11-09
Last updated
2009-01-06

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00555776. Inclusion in this directory is not an endorsement.